C122H107Cl4F8N35O5S5 — CID 162260490
N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chloro-2-fluorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2,6-dichlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-fluoro-3-(trifluoromethyl)benzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-(trifluoromethyl)benzamide (PubChem CID 162260490) has the molecular formula C122H107Cl4F8N35O5S5 and a molecular weight of 2597.57 g/mol. Its IUPAC name is N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chloro-2-fluorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2,6-dichlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-fluoro-3-(trifluoromethyl)benzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-(trifluoromethyl)benzamide.
| Compound Name | N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chloro-2-fluorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2,6-dichlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-fluoro-3-(trifluoromethyl)benzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-(trifluoromethyl)benzamide |
|---|---|
| PubChem CID | 162260490 |
| Molecular Formula | C122H107Cl4F8N35O5S5 |
| Molecular Weight | 2597.57 g/mol |
| Exact Mass | 2593.64 |
| IUPAC Name | N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-3-chloro-2-fluorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2,6-dichlorobenzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-fluoro-3-(trifluoromethyl)benzamide;N-[4-[4-(azetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-2-(trifluoromethyl)benzamide |
| SMILES | Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4c(Cl)cccc4Cl)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4cccc(C(F)(F)F)c4F)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4cccc(Cl)c4)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4cccc(Cl)c4F)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCC3)nc(Sc3ccc(NC(=O)c4ccccc4C(F)(F)F)cc3)n2)n[nH]1 |
| InChI | InChI=1S/C25H21F4N7OS.C25H22F3N7OS.C24H21Cl2N7OS.C24H21ClFN7OS.C24H22ClN7OS/c1-14-12-20(35-34-14)31-19-13-21(36-10-3-11-36)33-24(32-19)38-16-8-6-15(7-9-16)30-23(37)17-4-2-5-18(22(17)26)25(27,28)29;1-15-13-21(34-33-15)30-20-14-22(35-11-4-12-35)32-24(31-20)37-17-9-7-16(8-10-17)29-23(36)18-5-2-3-6-19(18)25(26,27)28;1-14-12-20(32-31-14)28-19-13-21(33-10-3-11-33)30-24(29-19)35-16-8-6-15(7-9-16)27-23(34)22-17(25)4-2-5-18(22)26;1-14-12-20(32-31-14)28-19-13-21(33-10-3-11-33)30-24(29-19)35-16-8-6-15(7-9-16)27-23(34)17-4-2-5-18(25)22(17)26;1-15-12-21(31-30-15)27-20-14-22(32-10-3-11-32)29-24(28-20)34-19-8-6-18(7-9-19)26-23(33)16-4-2-5-17(25)13-16/h2,4-9,12-13H,3,10-11H2,1H3,(H,30,37)(H2,31,32,33,34,35);2-3,5-10,13-14H,4,11-12H2,1H3,(H,29,36)(H2,30,31,32,33,34);2*2,4-9,12-13H,3,10-11H2,1H3,(H,27,34)(H2,28,29,30,31,32);2,4-9,12-14H,3,10-11H2,1H3,(H,26,33)(H2,27,28,29,30,31) |
| InChIKey | ZZEKUOARMQHSKX-UHFFFAOYSA-N |
| XLogP | 29.26 |
| TPSA | 494.15 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 179 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2597.57 |
| LogP ≤ 5 | 29.26 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 35 |